Beclomethasone Dipropionate (BDP)

DRUG2 trials

Sponsors

Chiesi Farmaceutici S.p.A., Organon and Co

Conditions

AsthmaSeasonal Allergic Rhinitis

Phase 2

An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects

CompletedNCT03084718

Chiesi Farmaceutici S.p.A.Asthma

Start: 2017-07-28End: 2018-12-05Updated: 2021-12-14

Phase 3

Safety and Efficacy of Mometasone Furoate (SCH 032088) vs Beclomethasone Dipropionate or Placebo in Seasonal Allergic Rhinitis (C93-013)

CompletedNCT03855189

Organon and CoSeasonal Allergic Rhinitis

Start: 1993-08-23End: 1993-10-22Updated: 2022-02-09

Related Papers

Efficacy and safety of inhaled extrafine beclomethasone dipropionate in adults with asthma: a randomized, parallel-group, dose-ranging study (BEAM)

Journal of Asthma2021-05-242 citations